Background: Prostate cancer is the most common cancer in a male of the reproductive system and associated with high mortality and Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive and advanced prostate cancer. Objective: The aim of this study was to assess the serum urea and creatinine beside the measure of serum electrolytes (Na and K) in patients with prostate cancer under (ADT).Methodology: 100 Sudanese patients with prostate cancer (PCa) under (ADT) attended in Khartoum oncology hospital, Khartoum state. The study conducted in April and July 2018. The age of PCa patients ranged between (50 to73 years) and their mean 62.2 years. The blood samples were taken from each patient.
Introduction
Prostate cancer is the second cancer leasing cause of death in elderly age associated with gene polymorphism (Cairns et al., 2001) . Androgen deprivation therapy (ADT) reduces testosterone levels leading to a hypogonadal condition marked by metabolic changes, such as hyperlipidemia, (Braga et al., 2006) increase blood glucose (Basaria,2008) , and an increase in fat contents (Braga e tal.,2006) . With respect to the renal system, hyperglycemia and Journal of Medical and Life Science , 2019, Vol.1, No. 1, P.29 -33 pISSN: 2636 -4093, eISSN: 2636 dyslipidemia may disrupt glomerular function by expanding and thickening the interstitial tubular membrane (Kambnam et al., 2001) .Furthermore, by lowering testosterone to castration levels, ADT may antagonize the vasodilating effects of testosterone on renal vessels (Molinari et al., 2002) .while also creating an estrogen deficiency, which can negatively affect renal tubular function (Hutchens et al., 2012) .
Prostate cancer has associated with end-stage renal disorders and also age-related (Wada et al., 2006) .
The objective of this study was to assess the serum urea and creatinine beside the measure of serum electrolytes (Na and K) in patients with prostate cancer under (ADT) therapy.
Materials and Methods

Study populations
This is a descriptive cross-sectional, hospital-based study, was carried in Khartoum state, Khartoum oncology hospital. The study period from April to July 2018. 100 subjects known diagnosed with prostate cancer under Androgen deprivation therapy were enrolled in this study. The age of PCa patients ranged between (50 and 73years) and their mean was 62.2 years. The most common clinical signs and symptoms of these patients were loss of weight, difficulty urination, hematuria, pain in the pelvis, headache, fever, stomach pain, nausea, vomiting, and diarrhea. And the main chemotherapy of these patients in this study includes Casodex, Zoladex, ondansetron and dosetaxal.
Samples and data collection
Samples were collected using dry, plastic syringes, tourniquet used to make the veins more prominent. A 3 ml blood sample was collected in heparin containers from each volunteer under septic conditions. The blood was centrifuged at 3000 r.p.m for 10 minutes which was stored in small aliquots and kept in a deep freezer (-20 C˚) until analyzed. The data were collected in patients using questionnaire form includes personal data such as age, clinical data includes (signs and type of chemotherapy) and laboratory data such as urea, creatinine, sodium, and potassium which is estimated in the laboratory. All reagents kits were obtained in the biosystem company. The urea and creatinine were estimated using spectrophotometer methods and also the serum electrolytes were measured by using flame photometers methods.
Inclusion criteria
Patients with prostate cancer under Androgen deprivation therapy.
Exclusion criteria
Patient with condition that affects plasma lipid level includes liver disease, renal diseases, malnutrition patient and diabetes mellitus.
Quality controls
The precision and accuracy of methods that used in this study were checked each time by using control material.
Ethical approval
This study approved from the committee of the department of clinical chemistry, Faculty of Medical
Laboratory
Sciences, Alneelain University, Khartoum, Sudan.
Statistical analysis
The data of this study were analyzed using the statistical package for social study (SPSS) software (version21). Student's t-test presented as (mean±SD).
A P-value of less than 0.05 was considered statistically significant.
Results
One hundred subjects known diagnosed prostate cancer under Androgen deprivation therapy were enrolled in this study. The age of PCa patients ranged between (50 and 73years). Overall, the mean age was Journal of Medical and Life Science , 2019, Vol.1, No. 1, P.29 -33   pISSN: 2636-4093, eISSN: 2636-4107 (62 ± 5.8) was presented in correlation between urea and creatinine and also between Na and K. Science , 2019, Vol.1, No. 1, P.29 -33   pISSN: 2636-4093, eISSN: 2636 -4107 Specifically, testosterone appears to protect the kidney by inducing vasodilatation in the renal vessels (Molinari et al., 2002) . Science , 2019, Vol.1, No. 1, P.29 -33   pISSN: 2636-4093, eISSN: 2636-4107 cause of prostate cancer. (Norlen et al.,1990) have reported that, changes in K level due to diluted water was used as an irritant. The exact cause of K level changes is not known. It is probably due to haemolysis during the absorption of fluid into circulation. Their no publish research study was done in Sudan concerning this study. And no data available has done in this research study.
Figure 1: distribution of age in the study
Conclusion:
This study concluded that androgen deprivation therapy not effected on blood renal parameters among prostate cancer, the levels of serum creatinine, urea and electrolytes in this study were reported within the normal ranges and also our study reported that the positive correlation between serum urea and creatinine.
